{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:47:47Z","timestamp":1781650067994,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clinbiochem.2017.03.015","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T20:47:53Z","timestamp":1489870073000},"page":"599-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants"],"prefix":"10.1016","volume":"50","author":[{"given":"Magdalena","family":"Krintus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kozinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Fabiszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kubica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Panteghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Sypniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0005","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure: the lancet lecture","volume":"385","author":"Braunwald","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/heart.83.5.596","article-title":"Epidemiology, aetiology, and prognosis of heart failure","volume":"83","author":"McMurray","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002528","article-title":"Established and emerging roles of biomarkers in heart failure clinical trials","volume":"9","author":"Ibrahim","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ejhf.273","article-title":"State of the art: newer biomarkers in heart failure","volume":"17","author":"de Boer","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2014.10.009","article-title":"Galectin-3 and heart failure: prognosis, prediction & clinical utility","volume":"443","author":"Filipe","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1515\/cclm-2014-0278","article-title":"Practical experience using galectin-3 in heart failure","volume":"52","author":"McCullough","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0040","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0045","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1515\/cclm-2016-0793","article-title":"Recommendation for the review of biological reference intervals in medical laboratories","volume":"54","author":"Henny","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ahj.2013.02.029","article-title":"Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results","volume":"165","author":"Wu","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0055","series-title":"Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. CLSI Document EP28A3c","author":"CLSI","year":"2010"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0060","first-page":"1657","article-title":"European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay","volume":"52","author":"Krintus","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijcard.2015.03.282","article-title":"Defining normality in a European multinational cohort: critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I","volume":"187","author":"Krintus","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cca.2016.09.020","article-title":"Impact of lipid markers and high-sensitivity C-reactive protein on the value of the 99th percentile upper reference limit for high-sensitivity cardiac troponin I","volume":"462","author":"Krintus","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0075","doi-asserted-by":"crossref","unstructured":"M. Kozinski, M. Krintus, J. Kubica et al., High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification, Crit. Rev. Clin. Lab. Sci. DOI: 10.1080\/10408363.2017.1285268 [article in press].","DOI":"10.1080\/10408363.2017.1285268"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0080","unstructured":"Abbott ARCHITECT STAT High Sensitive Troponin-I. Package insert 2013. G1-0139\/R02."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0085","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0090","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International expert committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"The International Expert Committee","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0095","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"A kidney disease: improving global outcomes chronic kidney disease guideline development work group members, evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0100","series-title":"Global Database on Body Mass Index, World Health Organization","author":"BMI Classification","year":"2006"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0105","unstructured":"Abbott ARCHITECT Galectin-3, Package insert 2013."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0115","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/clinchem\/17.4.275","article-title":"Influence of statistical method used on the resulting estimate of normal range","volume":"17","author":"Reed","year":"1971","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinbiochem.2012.09.014","article-title":"Performance characteristics of the ARCHITECT galectin-3 assay","volume":"46","author":"La'ulu","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2016.02.014","article-title":"Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors","volume":"456","author":"Mueller","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/cclm-2013-0942","article-title":"Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments","volume":"52","author":"Gaze","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0140","first-page":"307","article-title":"Analytical and clinical evaluation of the chemiluminescent microparticle immunoassay for galectin-3 determination","volume":"40","author":"Masotti","year":"2016","journal-title":"Biochem. Clin."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinbiochem.2010.02.001","article-title":"Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure","volume":"43","author":"Christenson","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2011.171082","article-title":"Influence of population selection on the 99th percentile reference value for cardiac troponin assays","volume":"58","author":"Collinson","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0155","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.clinbiochem.2013.08.004","article-title":"Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays","volume":"46","author":"Koerbin","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0160","doi-asserted-by":"crossref","first-page":"853-860.e4","DOI":"10.1016\/j.ahj.2014.02.011","article-title":"Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials","volume":"167","author":"Meijers","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119160","article-title":"The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonists","volume":"10","author":"Koukoui","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","author":"de Boer","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejheart.2004.03.014","article-title":"Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP\/NT-ANP and BNP\/NT-proBNP","volume":"7","author":"Hogenhuis","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/glycob\/cwu111","article-title":"Galectin-3: an emerging all-out player in metabolic disorders and their complications","volume":"25","author":"Pugliese","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijcard.2013.11.137","article-title":"Relationship between serum galectin-3 values and demographical or biochemical variables in patients without acute coronary syndrome","volume":"171","author":"Lippi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0190","article-title":"Circulating galectin-3 is associated with cardiometabolic disease in the community","volume":"5","author":"Nayor","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/en.2014-1374","article-title":"Galectin-3 activates PPARc and supports white adipose tissue formation and high-fat diet-induced obesity","volume":"156","author":"Baek","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.clinbiochem.2017.03.015_bb0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9343(01)00841-5","article-title":"Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction","volume":"111","author":"Krishnaswamy","year":"2001","journal-title":"Am. J. Med."}],"updated-by":[{"DOI":"10.1016\/j.clinbiochem.2017.07.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000}}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201730173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201730173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T02:59:03Z","timestamp":1601780343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201730173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":40,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S000991201730173X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.03.015","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.clinbiochem.2017.07.006","asserted-by":"object"}]},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing reference intervals for galectin-3 concentrations in serum requires careful consideration of its biological determinants","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}